Soni Medicare Ltd.

As of June 30, 2026, Soni Medicare Ltd. carries a market capitalization of 299.41M, placing it among publicly traded companies globally. Its enterprise value stands at 299.41M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Soni Medicare Ltd. has 4.27M shares outstanding.

These figures are as of June 30, 2026.

These figures are as of June 30, 2026. The EV/Sales ratio of 1.36 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 299.41M versus a market cap of 299.41M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

Over the twelve months ended June 30, 2026, Soni Medicare Ltd. recorded 808,000.00 in income tax expense. The company reported a pretax loss of -35.35M and -36.15M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on August 24, 2026, Soni Medicare Ltd.'s stock has declined approximately 6.46% over the past 52 weeks. The 50-day moving average sits at 61.01, while the 200-day moving average is 74.03.

Over the twelve months ended June 30, 2026, Soni Medicare Ltd. generated 219.84M in revenue and converted that into -36.15M in net income, yielding earnings per share of -8.44. EBITDA reached -16.61M, while operating income came in at -21.78M.

Over the twelve months ended June 30, 2026, Soni Medicare Ltd. posted a gross margin of 73.04, reflecting its pricing power and cost economics. The operating margin of -9.91 and net profit margin of -16.45 provide insight into operational efficiency.